Research suggests that 5-HTP may offer meaningful benefits for migraine prevention and headache relief, with the bulk of the evidence coming from randomized controlled trials comparing it to established drug treatments rather than placebo alone. Several RCTs found 5-HTP performed comparably to reference drugs such as methysergide and propranolol in reducing migraine frequency and severity, and a 1996 study in younger patients found that treatment was associated with improved beta-endorphin levels alongside reduced headache frequency and intensity, pointing to a possible mechanism involving the brain's natural pain-dampening system. However, the evidence is not uniformly positive — a crossover RCT in children found no meaningful difference between 5-HTP and placebo, a trial in chronic tension-type headache patients found no significant reduction in headache days during the treatment period, and a Cochrane review of pediatric migraine prophylaxis characterized the overall evidence base in that population as poor quality and too limited to support firm conclusions. Studies indicate that 5-HTP's effects on serotonin metabolism are likely central to whatever benefit is observed, but variability across populations, headache types, and study designs means the evidence remains promising yet incomplete, and no single trial was large enough to draw definitive conclusions.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| [Comparison of the effect of 5-hydroxytryptophan and propranolol in the inter... | RCT | 1991 | Supports | 97 |
| 5-Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Rando... | RCT | 1986 | Supports | 97 |
| Serotonin precursors in chronic primary headache. A double-blind cross-over s... | RCT | 1985 | Mixed | 93 |
| L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: a dou... | RCT | 1986 | Mixed | 92 |
| Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depre... | Other | 2018 | Supports | 88 |
| 5-OH-Tryptophane in migraine: clinical and neurophysiological considerations. | Other | 1981 | Supports | 85 |
| beta-endorphin in plasma and monocytes in juvenile headache. | RCT | 1996 | Supports | 82 |
| Drugs for preventing migraine headaches in children. | Systematic review | 2003 | Mixed | 78 |
| Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the ... | RCT | 1996 | Supports | 75 |
| Hemiplegic migraine, seizures, progressive spastic paraparesis, mood disorder... | Other | 2011 | Supports | 72 |
| L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a ... | RCT | 2000 | Mixed | 72 |
| Migraine headache: signs and symptoms, biochemistry, and current therapy. | Review | 1980 | Supports | 72 |
| Advances in the Microbial Synthesis of 5-Hydroxytryptophan. | Review | 2021 | Supports | 65 |
| Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy. | Other | 2017 | Supports | 62 |
| Serotonin metabolism in migraine. | Other | 1989 | Neutral | 60 |
| Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period. | Other | 2006 | Neutral | 58 |